Boothbay Fund Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-74,560
| Closed | -$112K | – | 1820 |
|
|
2023
Q1 | $112K | Buy |
74,560
+466
| +0.6% | +$699 | ﹤0.01% | 1650 |
|
|
2022
Q4 | $86.7K | Buy |
+74,094
| New | +$86.7K | ﹤0.01% | 1584 |
|
|
2022
Q3 | – | Sell |
-27,777
| Closed | -$44K | – | 2134 |
|
|
2022
Q2 | $44K | Buy |
+27,777
| New | +$44K | ﹤0.01% | 1817 |
|
|
2022
Q1 | – | Sell |
-14,258
| Closed | -$35K | – | 2047 |
|
|
2021
Q4 | $35K | Buy |
+14,258
| New | +$35K | ﹤0.01% | 1625 |
|